To assess the importance of antitumor immunity, we depleted CD8+ T lymphocytes and infused LGP-control or Olfr644−/− macrophages into tumor-bearing mice (Fig. 4j and Extended Data Fig. 6k,l). Here, CD8A is linked to neoplasm.